EV/EBITDA:
-16.99-0.82(-5.07%)Summary
- As of today, CGON EV/EBITDA is -16.99, with a fall of -0.82 (-5.07%) during the most recent trading session on October 24, 2025.
- Over the past year, CGON EV/EBITDA has increased by +3.04 (+15.18%).
- CGON EV/EBITDA is now -355.50% below its all-time high of -3.73.
Performance
CGON EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CGON EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -5.1% | +5.1% | +4.0% |
| 1M1 Month | -24.9% | +24.9% | +19.1% |
| 3M3 Months | -100.3% | +100.3% | +67.1% |
| 6M6 Months | -139.6% | +180.2% | +102.9% |
| YTDYTD | -35.1% | +85.1% | +52.3% |
| 1Y1 Year | +15.2% | +39.0% | +19.8% |
| 5Y5 Years | - | - | - |
CGON EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -13.50 | -25.9% | -17.38 | +2.2% |
| 3M | 3-Month | -7.42 | -129.0% | -17.38 | +2.2% |
| 6M | 6-Month | -7.09 | -139.6% | -17.38 | +2.2% |
| 1Y | 1-Year | -3.73 | -355.5% | -22.52 | +24.6% |
| 3Y | 3-Year | -3.73 | -355.5% | -94.71 | +82.1% |
| 5Y | 5-Year | -3.73 | -355.5% | -94.71 | +82.1% |
| All-Time | All-Time | -3.73 | -355.5% | -94.71 | +82.1% |
CGON EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -16.99(-35.1%) |
| Date | Value |
|---|---|
| 2024 | -12.58 |
FAQ
- What is CG Oncology, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for CG Oncology, Inc.?
- What is CGON EV/EBITDA year-to-date change?
- What is CG Oncology, Inc. EV/EBITDA year-on-year change?
What is CG Oncology, Inc. EV/EBITDA?
The current EV/EBITDA of CGON is -16.99
What is the all-time high EV/EBITDA for CG Oncology, Inc.?
CG Oncology, Inc. all-time high EV/EBITDA is -3.73
What is CGON EV/EBITDA year-to-date change?
CG Oncology, Inc. EV/EBITDA has changed by -4.41 (-35.06%) since the beginning of the year
What is CG Oncology, Inc. EV/EBITDA year-on-year change?
Over the past year, CGON EV/EBITDA has changed by +3.04 (+15.18%)